Thomson Reuters said on Thursday its business with the Department of Defense was "inaccurately represented," in response to accusations on social media by Elon Musk and U.S. President Donald Trump that the company played a role in "large scale social deception" for the government.
I recommend a buy rating for Thomson Reuters due to its solid organic growth outlook and sustained margins despite elevated AI-related investments. TRI's 4Q24 results showed a 5.4% y/y organic revenue increase, with the Big 3 segments growing 7.8% y/y organically, reflecting strong demand. AI-enabled products are driving growth, with Westlaw Precision adoption rising to 43% in 4Q24, indicating significant enterprise adoption and future growth potential.
Thomson Reuters Corporation (NYSE:TRI ) Q4 2024 Earnings Conference Call February 6, 2025 8:00 AM ET Company Participants Gary Bisbee - Head of Investor Relations Steve Hasker - Chief Executive Officer Mike Eastwood - Chief Financial Officer Conference Call Participants Scott Fletcher - CIBC Capital Markets Tim Casey - BMO Capital Markets George Tong - Goldman Sachs Gary Bisbee Thanks, Jenny. Good morning and thank you all for joining us today for our Fourth Quarter 2024 Earnings Call.
The headline numbers for Thomson Reuters (TRI) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Thomson Reuters (TRI) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.98 per share a year ago.
Beyond analysts' top -and-bottom-line estimates for Thomson Reuters (TRI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Thomson Reuters (TRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thomson Reuters (TRI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thomson Reuters has acquired tax automation company SafeSend in an all-cash transaction valued at $600 million.
Thomas Glocer, former Thomson Reuters CEO, joins 'Squawk on the Street' to discuss how policy is expected in the health care sector, how discussions are going regarding M&A, and much more.
I recommend a buy rating for Thomson Reuters stock due to its strong organic growth, driven by GenAI investments and price increases. TRI reported 8.2% y/y revenue growth in 3Q24, with 7.2% organic growth. The big 3 segments delivered 8.5% y/y organic growth, and TRI's GenAI products now account for 15% of annualized contract value.
Thomson Reuters achieved a +4% bottom line beat for Q3 2024, as its major business segments performed well. TRI's outlook is favorable, as the company revised its 2024 organic revenue growth guidance upwards and expressed confidence in achieving its 2025 and 2026 financial targets. I remain positive on Thomson Reuters, considering that the company's third quarter earnings and full-year organic revenue growth outlook were better than expected.